ANAVEX LIFE SCIENCES CORP. (NASDAQ:AVXL) Files An 8-K Other Events
Item 8.01 Other Events.
On September 13, 2019, Anavex Life Sciences Corp. (the “Company”) filed a prospectus supplement (the “Prospectus Supplement”) to its effective registration statement on Form S-3 (File No. 333-232550) registering shares of the Company’s common stock, $0.001 par value per share, issuable to its purchase agreement with Lincoln Park Capital Fund, LLC. This Current Report on Form 8-K is being filed solely to include the opinion of counsel attached hereto as Exhibit 5.1 with respect to the legality of the shares issuable to the Prospectus Supplement.
Item 9.01 Financial Statements and Exhibits.
|5.1||Opinion of Snell & Wilmer, L.L.P.|
|23.1||Consent of Snell & Wilmer, L.L.P. (contained in Exhibit 5.1)|
ANAVEX LIFE SCIENCES CORP. Exhibit
EX-5.1 2 f8k090419ex5-1_anavexlife.htm OPINION OF SNELL & WILMER,…
To view the full exhibit click